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Chemotherapy, radiotherapy, and endocrinotherapy are documented to induce
autophagy among breast cancer cells, but the role of autophagy in this disease
has been attributed as cytoprotective as well as tumor-suppressing. Thus we
studied MDA-MB-231 and SK-BR-3 breast cancer cell lines treated with epirubicin
(EPI) to assess autophagy and apoptosis. We found out that EPI induced apopto-
sis and autophagy in both cell lines. The lysosomal inhibitor bafilomycin A1
inhibited cellular autophagy and enhanced EPI-triggered apoptosis, perhaps due
to inhibition of autolysosome formation, which then inhibited autophagic effects
of engulfing and clearing damaged mitochondria. This inhibition increased mito-
chondrial cytochrome C release which augmented epirubicin-induced caspase-
dependent apoptosis and cytotoxicity. In addition, the lysosomal neutralizing
agent ammonia chloride (AC), and Atg7 knockdown by siRNA, could inhibit
epirubicin-triggered autophagy, enhance cytotoxicity, and increase caspase-
9- and caspase-3-dependent apoptosis. Thus, autophagy plays a prosurvival role
in EPI-treated MDA-MB-231 and SK-BR-3 cells, and autophagy inhibition can
potentially reverse this effect and increase the cytotoxicity of EPI.
B reast cancer is the most common malignancy among womenand chemotherapy is essential for care and cure.(1)
Epirubicin is a frequently used drug to treat breast cancer, but
resistance to EPI is common.(2–4)
Autophagy is an evolutionarily conserved lysosome-depen-
dent degradation in eukaryotes characterized by the hydrolysis
of engulfed autophagosomal materials by lysosomal acidic
enzymes.(5) Autophagy is a basal activity and increases when
cells are exposed to anoxia, poor nutrition, chemicals, and
radiation.(6,7) Studies by others have suggested that lysosomal
inhibitors, such as BAF and AC (NH4Cl) can be used to inhi-
bit autophagy(8–10) through the blockade of autolysosome for-
mation and autophagosomal content degradation.(11,12) In
addition, Atg gene knockdown could be an approach to pro-
duce autophagy inhibition.
How autophagy affects breast cancer is controversial(13);
some studies suggest that autophagy promotes type II pro-
grammed cell death,(14–17) but other reports indicate that autop-
hagy induced in breast tumor cells is cytoprotective and
reduces cell death.(18–22) Our previous work confirmed that
EPI induces cytoprotective autophagy with little apoptotic
death in MCF-7 cells,(21) but some reports suggest these events
are cell-line specific.(23,24) MCF-7 cells have defects in cas-
pase-3,(25,26) which is critical for apoptosis. Therefore, the
study of autophagy in other breast cancer cell lines is neces-
sary to investigate the effects of EPI.
Using MDA-MB-231 and SK-BR-3 breast cancer cell lines,
which have caspase-3 expression and distinct features with
respect to hormone receptors, we assessed EPI for induction of
autophagy and apoptosis. Bafilomycin A1 was investigated in
the cell lines for inhibition of autolysosome synthesis and
blockade of autophagy triggered by EPI. Such an autophagy-
inhibiting effect should increase apoptosis by promoting
release of Cyt C from mitochondria and enhance cytotoxicity.
Ammonium chloride and downregulation of ATG7 by siRNA
were also used and similar effects to BAF.
Materials and Methods
Cell culture, reagents, and antibodies. MDA-MB-231 and SK-
BR-3 breast cancer cells (Type Culture Collection of the Chi-
nese Academy of Sciences, Shanghai, China) were cultured at
37°C in RPMI-1640 and DMEM (Sigma-Aldrich, St Louis,
USA) respectively, and supplemented with 10% FCS,
100 units/mL penicillin, and 100 lg/mL streptomycin. Epiru-
bicin (diluted in DMEM) was from Pfizer Pharmaceuticals
(H20000496, New York, USA). Bafilomycin A1 (diluted in
0.5% DMSO, B1793), fluorescent dye MDC (30432), DAPI
(D8417), MTT (M2128), propidium iodine (p4170), and Try-
pan blue (T6146) were also from Sigma-Aldrich. Kits to mea-
sure caspase-9 activity (C1157), caspase-3 activity (C1116),
kits to isolate mitochondria (C3601) caspase-3 inhibitor Ac-
DEVD-CHO (C1206), and One-step TUNEL Apoptosis Assay
kit (C1088) were from Beyotime Institute of Biotechnology
(Shanghai, China). Rabbit anti-LC3 polyclonal antibody
(PM036) was from MBL Co. Ltd (Nagoya, Japan). Mouse
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anti-GAPDH mAb (200306-7E4), mouse anti-COX IV mAb
(200147), rabbit anti-Atg7 pAb (500691), and rabbit anti-p62
pAb (614662) were from Zen Bioscience (Chengdu, China).
Mouse anti-b-actin (C4) mAb was from Santa Cruz Biotech-
nology (Sc-47778, Dallas, USA). The si-Atg7 (with sequence
50-GGUCAAAGGACGAAGAUAATT UUAUCUUCGUCCUUU
GACCTT-30) and control siRNA were synthesized by Gene-
Pharma (Shanghai, China) and the primer (forward primer,
agttgtttgcttccgtgac; reverse primer, tgcctcctttctggttctt) for
detecting si-Atg7’s interference efficiencies through RT-qPCR
was synthesized by Sangon Biotech (Shanghai, China).
Cytotoxicity assay through MTT. MDA-MB-231 and SK-BR-3
cells were seeded in 96-well flat-bottomed plates at 8 9 103
and 1.2 9 104 per well, respectively. Medium containing vari-
ous concentrations of BAF were added and cultured at 37°C
for 24, 48, and 72 h. Inhibition was measured to select for
subsequent experiments the appropriate dose of BAF and
exposure time that inhibited autophagy without cytotoxicity.
Monodansylcadaverine sequestration assay. Cells were seeded
at 5 9 105 (MDA-MB-231) and 7 9 105 (SK-BR-3) in 6-well
flat-bottomed plates, and cultured for 24 h at 37°C. The cells
were then treated with EPI, BAF, EPI + BAF (EPI concentra-
tion was IC50 at 48 h for each cell line), and plain medium
added to the control group (control group in all other assays
were also treated with plain medium). All the cells were then
cultured for 48 h in total at 37°C. During the incubation an
additional dose of BAF was added to the BAF and EPI + BAF
groups 24 h before harvesting cells. All cells were treated with
0.1 mM MDC for 1 h at 37°C counted, and then collected at
same amount via centrifugation at 600 g for 5 min. Then
400 lL lysis buffer was added to samples that were incubated
on ice with light agitation for 30 min and centrifuged at
13,000 g for 10 min to extract the supernatant. Fluorescence
of the supernatant was measured at 535 nm (emission) and
340 nm (excitation) with a microplate fluorometer (Bio-Rad,
Hercules, USA).(27)
Western blot analysis of LC3-II and p62. Cells were seeded in
25-cm2 cell culture flasks (3 9 105 for MDA-MB-231 and
5 9 105 for SK-BR-3) and treated with EPI, BAF, and
EPI + BAF. Cells were centrifuged and then treated with
RIPA lysis buffer (Beyotime) to obtain whole cell lysates.
Then 30 lg protein from each group was separated by 15%
SDS-PAGE and transferred to PVDF membranes. After block-
ing, PVDF membranes were incubated with primary antibodies
against LC3, p62 (1:1000), and b-actin (1:2500) according to
the manufacturer’s recommendations. Membranes were then
washed with Tris-buffered saline–Tween 20, and incubated
with secondary antibodies for 1 h at room temperature. The
bands were visualized and analyzed by a chemiluminescence
detection system (Bio-Rad).
Measurement of autophagosomes and autolysosomes after
mRFP-EGFP-LC3 transfection. Cells were seeded on coverslips in
6-well plates (1.0 9 106 for MDA-MB-231 and 1.2 9 106 for
SK-BR-3). The plasmids of Mammalian expression of rat LC3
fused to monomeric Red Fluorescent Protein(mRFP) and
Enhanced Green Fluorescent Protein(EGFP), also named
ptfLC3 Plasmids, were transfected into cells with Lipofec-
tamine 2000 (Thermo Fisher Scientific, Waltham, USA)
according to the manufacturer’s instructions. Twenty-four
hours after transfection, cells were treated with EPI or
EPI + BAF. The GFP and RFP fluorescence were measured
under a fluorescent microscope (Nikon, Tokyo, Japan), and
captured images of both GFP and RFP were merged. Red fluo-
rescence indicated autolysosomes and yellow fluorescence, due
to merging of both green and red fluorescence, indicated
autophagosomes.(28,29)
Cell death assay using Trypan blue exclusion. MDA-MB-231
and SK-BR-3 cells were seeded at a density of 4 9 105 and
6 9 105, respectively, in 6-well plates and divided into seven
groups, EPI, BAF, EPI + BAF, and control group, as described
above, as well as Ac-DEVD-CHO, Ac-DEVD-CHO + EPI,
and Ac-DEVD-CHO + EPI + BAF, which were treated with
20 lM Ac-DEVD-CHO for 48 h at 37°C. Cells were harvested
by digestion and centrifugation then stained with Trypan blue.
Dead cells were counted to estimate cell death.
40,60-Diamidino-2-phenylindole dihydrochloride staining. Cells
were seeded on coverslips in 6-well plates and divided into
control, BAF, EPI, and EPI + BAF treatment groups. Both
attached and detached cells were collected and fixed with 4%
paraformaldehyde for 10 min in 4°C. Fixed cells were then
stained with DAPI for 15 min at 37°C in the dark, and fluores-
cence of DAPI was measured under a fluorescent microscope.
Propidium iodide staining and cell cycle assay for sub-G popu-
lations. Cells were seeded on coverslips in 6-well plates and
divided into BAF, EPI, EPI + BAF, and control groups. After
treatment cells were harvested by centrifugation, they were
fixed with 75% ethanol for 24 h at 20°C. The cells were
washed, stained with propidium iodide, and measured by flow
cytometry (Beckman, Coulter, Pasadena, USA) at 488 nm.
Terminal deoxynucleotidyl transferase dUTP nick end labeling
assay. The TUNEL assay was carried out using a One-Step
TUNEL Apoptosis Assay Kit. Cells were seeded on coverslips
in 6-well plates, and divided into control, BAF, EPI, and
EPI + BAF treatment groups. Both attached and detached cells
were collected and fixed with 4% paraformaldehyde for 1 h at
room temperature, then were treated with 0.5% Triton X-100
for 15 min at room temperature. The TUNEL reaction mixture
was prepared according to the manufacturer’s instructions and
applied to cells for 1 h at 37°C in the dark in a humidified
atmosphere. We also used DAPI to stain nuclei simultane-
ously. The TUNEL-positive cells were counted under a fluo-
rescence microscope.
Mitochondrial membrane potential assay. Cells were seeded
on coverslips in 6-well plates and treated with or without EPI
for 48 h, and incubated with 5 lg/mL rhodamine 123 for
10 min at 37°C. After incubation with rhodamine 123, cells
were washed twice and incubated with fresh medium at 37°C
for 1 h, and then incubated with PBS with 1 lg/mL DAPI at
37°C for 10 min. Cells were then observed under a fluores-
cence microscope.
Transmission electron microscopy. Both EPI-treated and con-
trol cells were fixed with a solution containing 3% glutaralde-
hyde in 0.1 M PBS (pH 7.3). The fixed cells were post-fixed
with 1% osmic acid for 2 h then dehydrated in increasing con-
centrations (50% ? 70% ? 90% ? 100%) of acetone, infil-
trated with Epon-812 epoxy resin and pure acetone (1:1)
solution for 30 min, and infiltrated with Epon-812 for 2 h. The
samples were embedded in an Epon-812 embedding kit at 40°C
for 12 h, then at 70°C for 24 h. Ultrathin sections were sliced
using the Leica EM UC6 microtome (Leica, Wetzlar, Germany),
then stained with uranyl acetate and lead citrate in a Leica EM
stainer and examined using an H7650 transmission electron
microscope (Hitachi, Tokyo, Japan) at an accelerating voltage of
80 kV. Digital images were obtained using the Hitachi TEM
System.
Caspase-3 and caspase-9 activity assay. Cells were seeded in 6-
well plates and divided into control, BAF, EPI, and EPI + BAF
treatment groups. Thirty microliters of lysis buffer provided in
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the assay kit was added to resuspend the collected cells, followed
by incubating on ice with light agitation for 30 min. The super-
natants were collected after cells were centrifuged at 13 000 g for
10 min. Then 10 lL supernatant was used for measuring protein
using Bradford reagent. Another 20 lL was used to assay cas-
pase-3 and caspase-9 activity. Caspase-3 was assayed with Ac-
DEVD-qNA as substrate and caspase-9 with Ac-LEHD-qNA.
Both were incubated at 37°C for 4 h and OD values were read at
405 nm with a microplate reader.
Cytochrome c release measured with Western blot analy-
sis. MDA-MB-231 cells (4 9 106) and SK-BR-3 cells
(6 9 106) were seeded in 75-cm2 cell culture flasks and trea-
ted with BAF, EPI, EPI + BAF, or control medium. Cells
were collected, counted, and placed on ice for 30 min. Sam-
ples were then homogenized and cytoplasmic and mitochon-
drial protein lysates were separated by differential
centrifugation (whole cell lysates was centrifuged at 1000g for
10 min to obtain the supernatant. The acquired supernatant
was centrifuged at 3500g for 10 min and collected. Protein of
each sample was measured with bicinchoninic acid reagent,
and 50 lg protein was selected for Cyt C measurement using
Western blot with GAPDH as an internal reference for cyto-
plasmic protein and COX-IV was the internal reference for
mitochondrial protein. Anti-GAPDH was diluted to 1:2500,
anti-COX-IV was diluted to 1:1500, and anti-Cyt C was
diluted to 1:1000. Goat anti-mouse and goat anti-rabbit sec-
ondary antibodies were diluted to 1:10 000.
Effect of AC on autophagy, cytotoxicity, and apoptosis in EPI-
treated breast cancer cells. A group of assays including MDC
sequestration, Trypan blue, and caspase activity assay were
carried out. In both MDC and caspase activity assays, cells




Fig. 1. Epirubicin (EPI) induced autophagy and
bafilomycin A1 (BAF)’s effect on it. (a) MDA-MB-231
and SK-BR-3 cells were treated with BAF, EPI, or
EPI + BAF and monodansylcadaverine (MDC)
sequestration was measured. Optical density (OD)
values are from three independent experiments. (b)
Cells were treated with BAF, EPI, EPI+BAF and
control, and microtubule-associated protein 1 light
chain 3 form II (LC3-II) (14 kDa) expression was
measured. Intensity values and LC3-II data are from
three independent experiments. (c) Cells were
treated as described and p62 (62 kDa) expression
was measured. Intensity values and LC3-II data are
from three independent experiments.
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
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AC, EPI, or EPI + AC. In the Trypan blue assay,
EPI + AC + Ac-DEVD-CHO was an additional group. For AC
treatment, 10 mM AC was added to cells 24 h before harvest-
ing. The MDC sequestration, Trypan blue, and caspase activity
assays were carried out as described above.
Downregulation of Atg7 with siRNA. The si-Atg7 and control
siRNA were transfected into MDA-MB-231 and SK-BR-3 by
Lipofectamine 2000. The interference efficiencies of siRNAs
were determined through Real-time qPCR and Western blot
analysis. Real-time qPCR was undertaken with the primers.
For Western blot analyses, each whole cell lysates sample was
electrophoresed in 10% SDS-polyacrylamide gels, and then
blotted onto PVDF membranes. Primary antibodies against
Atg7 (1:1000) and b-actin (1:2000) were used following the
manufacturer’s recommendations. The results were visualized
by the chemiluminescence detection system.
(a)
(b)
Fig. 2. Detection of autophagosomes and
autolysosomes was carried out under fluorescence
microscopy after transfection of breast cancer cell lines
with monomeric red fluorescent protein (mRFP)–
enhanced GFP (EGFP)–microtubule-associated protein
1 light chain 3. MDA-MB-231 (a) and SK-BR-3 (b) cells
were transfected as described and 24 h later treated
with control, EPI and EPI + BAF. GFP and RFP
fluorescence were imaged under a microscope (9600).
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To study the effect of si-Atg7 on autophagy and apoptosis in
EPI-treated cells, cells transfected with si-Atg7 or control
siRNA and cells without transfection were collected, allowed
to grow overnight, and divided into different groups. In both
the MDC and caspase activity assay, the groups were siAtg7,
EPI, EPI + siAtg7, and EPI + control siRNA. In the Trypan
blue assay, the EPI + siAtg7 + Ac-DEVD-CHO-treated group
was included with the five groups above. All of these assays
were carried out as described above.
Statistical analyses. Data are from three independent experi-
ments. Statistical comparisons of means were undertaken with
ANOVA and P ≤ 0.05 was considered statistically significant.
Results
Epirubicin induced autophagy in MDA-MB-231 and SK-BR-3
cells, and BAF inhibited EPI-induced autophagy by blocking
autolysosome formation. Epirubicin treatment of both cell lines
revealed an IC50 at 48 h of 3.0 lM in MDA-MB-231 cells and
2.0 lM in SK-BR-3 cells. Bafilomycin A1 (5, 10, and 20 nM)
were not cytotoxic to either cell line at 24 h (Fig. S1), so 24 h
of treatment with 20 nM BAF was chosen for experimental
treatments.
The OD of MDCs for each treatment was measured and con-
trols and BAF samples were not significantly different. Fluo-
rescence of MDC in EPI-treated cells significantly increased in
both cell lines compared to controls. Fluorescence after
EPI + BAF treatment decreased compared to EPI treatment
(Fig. 1a). Levels of LC3-II protein did not change after BAF
treatment in either cell line, but increased after EPI treatment
and increased further after EPI + BAF treatment (Fig. 1b).
The p62 protein level significantly reduced after EPI treatment
in both cell lines, whereas the combination of EPI and BAF
reversed this trend. Bafilomycin A1 alone did not show any
significant increase (Fig. 1c).
After cell transfection to assess autolysosome populations,
measurement of fluorescence in controls revealed little or no
fluorescence in either cell line. Treatment with EPI caused
(a) (b)
Fig. 3. Cell death in MDA-MB-231 (a) and SK-BR-3
(b) breast cancer cell lines after treatment with
epirubicin (EPI) with or without bafilomycin A1
(BAF) and 50 lM Ac-DEVD-CHO for 48 h. Cell
viability was measured with Trypan blue assay. Data
were from three independent experiments.
(a)
(b)
Fig. 4. Apoptosis assay in MDA-MB-231 and SK-
BR-3 breast cancer cells after treatment epirubicin
(EPI) with or without bafilomycin A1 (BAF). (a)
Propidium iodide stained cells were assessed for
sub-G1 populations. (b) DAPI stained cells observed
under a fluorescence microscope (9600) indicated
apoptosis (apoptotic cells are indicated with red
arrows). Data are from three independent
experiments.
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
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greater red fluorescence of mRFP in both cell lines and this
exceeded the green fluorescence of enhanced GFP. Merging
images in a photofluorogram confirmed that most fluorescence
was attributed to autolysosomes. In cells treated with
EPI + BAF, both red and green fluorescence increased signifi-
cantly, but in the merged photofluorogram, most fluorescence
was attributed to autophagosomes that were not combined with
lysosomes (Fig. 2).
According to a report by Mizushima and Yoshimori,(30) the
increase of LC3-II indicates the increase of autophagosomes,
which can be caused by either increased autophagic flux or
inhibition of autolysosomes formation. Both p62 and p62-
bound polyubiquitinated proteins become incorporated into the
completed autophagosome and are degraded in autolysosomes,
thus also serving as read-out of autophagic degradation. These
results indicated that EPI induced autophagy in both cells, and
BAF inhibited EPI-induced autophagy by inhibiting the forma-
tion of autolysosomes.
Epirubicin induced apoptosis in MDA-MB-231 and SK-BR-3 cells
and blocking autophagy by BAF boosted EPI-triggered apopto-
sis. Trypan blue assay was used to assess cell death rate. We
discovered that 24 h of treatment of 20 nM BAF was not cyto-
toxic to either cell line, nor was the caspase-3 inhibitor Ac-
DEVD-CHO. However, Ac-DEVD-CHO decreased cell death
induced by EPI in both of the cell lines, and EPI + BAF sig-
nificantly increased cell death compared to EPI. In addition,
Ac-DEVD-CHO treatment decreased cell death induced by
EPI + BAF in both cell lines (Fig. 3).
Fig. 5. Terminal deoxynucleotidyl transferase dUTP nick end (TUNEL) staining of MDA-MB-231 and SK-BR-3 breast cancer cells treated with
epirubicin (EPI) with or without bafilomycin A1 (BAF). Light green cells are TUNEL-positive staining cells. The percentage of TUNEL-positive cells
was determined by counting cells in at least eight fields and more than 500 cells in total. Data were from three independent experiments.
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Sub-G populations of cells were measured in both cell lines.
Bafilomycin A1 treatment alone did not alter the number of sub-
G cells in either cell line, but EPI significantly increased sub-G
cells in G2/M arrest. Treatment with EPI + BAF increased the
number of sub-G cells more than EPI alone (Fig. 4a).
Normal cells showed intact nuclei and equally chromatin
and apoptotic cells showed chromatin condensation, nuclei
fragmentation, cell shrinkage, or even apoptotic body. These
nuclear changes typical of apoptosis can be detect through
DAPI staining.(31,32) Our results indicated that BAF did not
cause apoptosis compared to controls, but EPI increased apop-
totic cells in both cell lines and this was increased even more
after EPI + BAF treatment (Fig. 4b). Staining with TUNEL
also showed that apoptotic cells occurred under EPI treatment,
and EPI + BAF enhanced this effect (Fig. 5).
These results indicated that EPI triggered apoptosis in both
cell lines, and increased further under treatment with
EPI + BAF.
Bafilomycin A1 enhanced EPI-triggered mitochondrial intrinsic
apoptotic pathway. The MMP was lost in both cell lines after
48 h of treatment with EPI (Fig. S2). Electron microscopy was
used to further identify the effect of EPI on mitochondria.
The results showed that mitochondria became swollen in
EPI-treated cells, and mitochondria-like structures could be
observed in some autophagosomes (Fig. 6). It was suggested
that MMP is damaged when MDA-MB-231 and SK-BR-3 cells
are treated with EPI, but EPI-induced autophagy could engulf
the damaged mitochondria in both cell lines.
In Western blot analysis, the increase of Cyt C in cytoplasm
following a decrease in mitochondria indicates the release of
Cyt C. Cytochrome C release was increased after EPI treat-
ment and EPI + BAF increased Cyt C release further. Bafilo-
mycin A1 treatment did not change Cyt C compared to control
(Fig. 7a). Caspase-9 and -3 activities were measured with
spectrophotometry. The activity of both caspases was increased
after EPI treatment in both cell lines, and increased further
Fig. 6. Structures of mitochondria and autophagosomes were analyzed by electron microscopy (915 000 and 940 000) after cells were treated
with or without epirubicin (EPI). In higher magnification images, the white arrows indicate the structures of mitochondria; the black arrows indi-
cate the structures of autophagsomes that contain mitochondria-like structures.
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
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after EPI + BAF treatment. Bafilomycin A1 did not alter their
activities (Fig. 7b).
The release of Cyt C from mitochondria to cytoplasm
together with enhanced caspase-3 and -9 activities are consis-
tent with the mechanism of mitochondrial intrinsic apoptosis,
and these results suggested that EPI induced mitochondrial-
dependent apoptosis in both cell lines; EPI + BAF further
enhanced this trend in both cells, probably correlated with
BAF’s effect of inhibiting EPI-triggered autophagy as BAF
alone could affect neither apoptosis nor autophagy.
Ammonium chloride inhibited autophagy and enhanced cyto-
toxicity of EPI in breast cancer cells with increasing caspase-3 and
-9. The MDC sequestration assay showed that the OD value
of EPI + AC significantly decreased compared with the EPI-
treated group in both cell lines, whereas AC alone did not show
such an effect compared with the control group (Fig. 8a). Try-
pan blue assay showed that AC enhanced EPI-induced cell
death, whereas Ac-DEVD-CHO reduced the cell death rate
compared with the EPI + AC-treated group (Fig. 8b). In cas-
pase-3 and -9 activity assays, EPI + AC treatment significantly
increased the activities of both caspase-3 and -9 compared with
EPI treatment alone (Fig. 8c). These results suggest that, similar
to BAF, AC also inhibits EPI-induced autophagy in breast can-
cer cells MDA-MB-231 and SK-BR-3, and increases cell death
as well as caspase-9 and caspase-3-dependent apoptosis.
Inhibition of autophagy by si-ATG7 increased cytotoxicity of
EPI in breast cancer cells. The Atg7 RT-qPCR analysis showed
that the specific si-Atg7 downregulated Atg7 by 60–70%
(Fig. 9a) compared with siRNA control. Western blot analysis
also showed that Atg7 protein level significantly decreased in
si-Atg7 transfected cells compared with cells transfected with
control siRNA (Fig. 9b).
The results of MDC sequestration assay showed that the
combination of EPI + si-Atg7 reduced the OD value compared
(a)
(b)
Fig. 7. Cytochrome C (Cyt C) release and caspase-3 and -9 activities were measured in MDA-MB-231 and SK-BR-3 breast cancer cells after treat-
ment with control, BAF, EPI and EPI + BAF. (a) GAPDH was an internal control for cytosolic fractions and COX IV was a control for mitochondrial
fractions. Intensity values and ratios of COX IV to controls are from three independent experiments. (b) MDA-MB-231 and SK-BR-3 cells were
treated as depicted in Methods. Caspase-3 and -9 activities were assayed with Ac-DEVD-pNA and Ac-LEHD-pNA, respectively. Opitcal density val-
ues and fold-change data are from three independent experiments.
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with the EPI group (Fig. 9c). In addition, the death rate of
cells treated with siATG7 + EPI was significantly boosted
compared with EPI alone, and this trend can clearly be dimin-
ished by Ac-DEVD-CHO (Fig. 9d). Caspase-9 and -3 activities
were also enhanced when combined with EPI and si-Atg7
(Fig. 9e). Control siRNA showed no such effect when com-
bined with EPI. These results showed that Atg7 knockdown
through siRNA inhibits autophagy, enhances apoptosis through
caspase-9 and -3, and increases cytotoxicity in both cell lines
treated with EPI.
Discussion
Previously we reported that MCF-7 cells treated with EPI did
not undergo apoptosis but that autophagy was triggered, and
blocking autophagy significantly induced apoptosis and
increased toxicity of EPI. Thus, EPI-induced autophagy
reduced apoptosis in MCF-7 cells.(21) Published reports
indicate that different cytotoxic agents induce autophagy in
MCF-7 cells with little apoptosis, and blocking autophagy dra-
matically increased apoptosis.(27,33) Different breast cancer cell
lines may have different responses after treatment with the
same agents: Choi’s group reported that cordycepin-treated
MCF-7 cells undergo autophagy-associated cell death with
little apoptosis, but cordycepin-induced cell death in MDA-
MB-231 cells is chiefly through apoptosis.(24) MCF-7 cells
do not express caspase-3, a critical molecule in the apoptosis
pathway.(25,26) Although MCF-7 cells can undergo apoptosis
through a cascade reaction of caspase-6, -7, and -9,(34) or MDA-
MB-231 cells may undergo caspase-3-independent apoptosis
after treatment with other agents,(35) some other reports show
that the lack of caspase-3 inhibits apoptosis in MCF-7
cells,(36,37) and specific knockdown of caspase-3 in MDA-MB-
231 cells renders them resistant to cytotoxic agents.(38) There-
fore, a caspase-3 defect may decrease apoptosis in MCF-7
cells treated with EPI, but MDA-MB-231 and SK-BR-3 cell
lines may undergo apoptosis after EPI treatment. However, the
effect of caspase-3 in controlling both apoptosis and autophagy
requires further study. Interestingly, our results also show that
EPI induced G2/M arrest in both cell lines and these data were
similar to previous work with EPI and MCF-7 cells.(39)
Reports also suggest that EPI may not necessarily trigger
autophagy in other breast cancer cells,(40) so how cells respond
to EPI treatment is more complex than “either autophagy or
apoptosis”, and requires further study.
Some studies suggest that autophagy can promote cell death
in breast cancer with a sufficient stimulus or when apoptosis is
inhibited. In contrast, autophagy may be triggered by cytotoxic
agents to prevent cell death and inhibitors of autophagy




Fig. 8. Effect of ammonium chloride (AC) on
autophagy and apoptosis in epirubicin (EPI)-treated
MDA-MB-231 and SK-BR-3 breast cancer cells. (a)
Cells were treated with EPI for 48 h with or
without 10 mM AC (added 24 h before harvesting),
then stained with 0.1 mM monodansylcadaverine
(MDC) for 1 h before MDC sequestration was
measured. Optical density (OD) values are from
three independent experiments. (b) Cells were
treated with EPI and 50 lM Ac-DEVD-CHO (ADC)
for 48 h and/or 10 mM AC (added 24 h before
harvesting), and cell viability was measured with
Trypan blue assay. Data of cell death rate were
from three independent experiments. (c) Cells were
treated as indicated in (a), and caspase-3 and -9
activities were assayed with Ac-DEVD-pNA and Ac-
LEHD-pNA, respectively. OD values and fold-change
data are from three independent experiments.
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
on behalf of Japanese Cancer Association.
Cancer Sci | November 2016 | vol. 107 | no. 11 | 1618
Original Article
less autophagy, more breast cancer cell death by EPI www.wileyonlinelibrary.com/journal/cas
study confirmed that blocking EPI-induced autophagy
increased caspase-9-dependent intrinsic apoptosis and pro-
moted cell death.(21) Here, we report that EPI triggered both
apoptosis and autophagy in MDA-MB-231 and SK-BR-3 cells,
and inhibited autophagy with BAF induced apoptosis and sen-
sitized cells to EPI. These data agree with previous findings in
MCF-7 cells and are consistent with a report that autophagy
inhibition enhances the therapeutic response in both anthracy-
cline-sensitive and -resistant MDA-MB-231 cells.(42) Another
report shows that trastuzumab, an anti-human epidermal
growth factor receptor 2 mAb, induced cytoprotective autop-
hagy in SK-BR-3 cells.(43) In summary, autophagy induced by
cytotoxic agents may either inhibit or promote survival in
breast cancer cells, and the factors to decide between two
opposite effects is worthy of further study.
How autophagy decreases cell death is unclear, but inhibi-
tion of intrinsic apoptosis may occur by autophagosomes con-
suming damaged mitochondria coupled with reduced Cyt C
released in treated cells.(44–46) Cytochrome C release is neces-
sary for intrinsic apoptosis because it cleaves/activates cas-
pase-9 and, eventually, downstream caspase-3. Our former
report showed that MMP was damaged in MCF-7 cells treated
with EPI, but activation of caspase-9 did not occur.(21) This
study indicates that most MDA-MB-231 and SK-BR-3 cells
treated with EPI lost MMP and Cyt C release increased, as did
activation of caspase-9 and -3. Inhibition of autophagy with
BAF promoted this effect and increased apoptosis. Therefore,
protective effects of autophagy in EPI-treated breast cancer
cells may involve autophagic consumption of mitochondria
and less Cyt C release to inhibit EPI-induced mitochondrial
intrinsic apoptosis. Other studies indicate that different mecha-
nisms contribute to cytoprotective autophagy induced by vari-
ous cytotoxic agents in breast cancer cells, including reactive
oxygen species and the inositol requiring enzyme 1 signaling
pathway.(35,47,48) Autophagy may protect breast cancer cells
through multiple mechanisms and these might be drug-specific;
this also warrants further study.
In autophagy studies, both BAF and AC are often used as
autophagy inhibiting agents.(29,49) Bafilomycin A1, from the
bafilomycin family of toxic macrolide antibiotics, specifically
inhibits the vacuolar-type H+-ATPase, and thus prevents the





Fig. 9. Effect of Atg7 knockdown on autophagy and apoptosis in epirubicin (EPI)-treated MDA-MB-231 and SK-BR-3 breast cancer cells were
measured after cells were transfected with siAtg7 or control siRNA. (a) Measurements of Atg mRNA expression by real-time quantitative PCR
with b-actin as the reference gene after transfection. (b) Measurements of Atg7 protein level were carried out by Western blot after transfec-
tion. (c) Cells were treated with or without EPI, and stained with 0.1 mM monodansylcadaverine (MDC) for 1 h, and MDC sequestration was
measured with a microplate fluorometer. (d) Cells were treated with or without EPI, and with or without Ac-DEVD-CHO (ADC) for 48 h, and the
cell death rate was measured by Trypan blue assay. (e) Cells were treated with EPI for 48 h, and caspase-3 and -9 activities were assayed with Ac-
DEVD-pNA and Ac-LEHD-pNA, respectively. All values and fold-change data are from three independent experiments.
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between autophagosomes and lysosomes, and ultimately inhibits
autophagy.(11) Ammonia chloride is a weak base that could
become protonated and accumulates inside lysosomes, elevating
the pH and inactivating lysosomal hydrolases. This change in
pH inhibits the fusion of autophagosomes with lysosomes.(50)
In our study, we observed that both BAF and AC could inhibit
EPI-induced autophagy in breast cancer cells, and could
enhance apoptosis as well as cytotoxicity. Another approach to
inhibit autophagy is through Atg gene knockdown. The Atg
family of autophagy regulatory proteins regulate the formation
of autophagosomes during the initiation of autophagy. This
includes Atg7, which plays a predominant role in maturation of
autophagic vacuoles by engaging other proteins to the
autophagosomal membrane.(51) We found that in different breast
cancer cell lines, downregulation of Atg7 significantly reversed
EPI-triggered autophagy, and increased apoptosis as well as cell
death.(21) Different autophagy inhibitors including BAF, AC,
and si-Atg7 all sensitize breast cancer cells to EPI.
Thus, EPI induced both autophagy and apoptosis in MDA-
MB-231 and SK-BR-3 cells and autophagy reduced cell death
by engulfing damaged mitochondria and inhibiting mitochon-
drial intrinsic apoptosis. Autophagy inhibition through chemi-
cal agents like BAF and AC or knockdown of the Atg gene,
such as Atg7, enhanced apoptosis and sensitized EPI-treated
cells. Therefore, it is suggested that inhibition of autophagy
may contribute to enhanced curative effects of EPI in breast
cancer therapy. However, the molecular mechanism of
autophagy and EPI-resistance in breast cancer cells still
requires in-depth studies, and blockade of autophagy enhanc-
ing apoptosis and sensitizing breast cancer under treatment
must be further verified by study in vivo.
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Fig. S1. Cell viability measured in SK-BR-3 (a) and MDA-MB-231 (b) cells treated with bafilomycin A1 (BAF) for 0, 24, 48, and 72 h. Results
are from three independent experiments.
Fig. S2. Mitochondria membrane potential (MMP) was detected by rhodamine 123 (Rh123) and DAPI after cells were treated with epirubicin
(EPI). The fluorescence of Rh123 and DAPI was observed by fluorescence microscope (9200).
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